AMANDA VOTTO: Open Payments
NPI 1053417535 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 57 payments from 18 companies in 2025. Trend: 2023 $1,129 · 2024 $852 · 2025 $1,345
Food & beverage: $1,260Education: $85
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $223 |
| Esperion Therapeutics, Inc. | 6 | $175 |
| PFIZER INC. | 10 | $168 |
| Abbott Laboratories | 2 | $159 |
| BridgeBio Pharma, Inc. | 5 | $121 |
| SCPHARMACEUTICALS INC. | 5 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
Products named: Wegovy, NEXLETOL, CARDIOMEMS, Attruby, VYNDAQEL, FUROSCIX, ELIQUIS, FARXIGA.
Industry payments across MA — which companies pay providers there.
